Enteric fever, predominantly caused by Salmonella Typhi and Paratyphi, continues to pose significant health challenges globally. An integrated approach is crucial to effectively manage this disease and reduce its burden. This article outlines comprehensive strategies for healthcare professionals.
Timely recognition of enteric fever is pivotal. Clinical presentation can vary, with symptoms ranging from fever, headache, and abdominal pain, to constipation or diarrhoea. Laboratory confirmation, through blood or bone marrow culture, is the gold standard. Rapid diagnostic tests, like Widal and Typhidot, can also be useful.
Antimicrobial therapy remains the cornerstone of enteric fever management. Resistance to first-line drugs like chloramphenicol, ampicillin, and trimethoprim-sulfamethoxazole has led to the preferential use of fluoroquinolones. However, emerging resistance necessitates susceptibility testing to guide therapy. Newer agents like azithromycin and third-generation cephalosporins are promising alternatives.
Preventive measures, such as vaccination, play a crucial role in enteric fever management. Two vaccines, Vi polysaccharide and Ty21a, are currently available. While they do not provide complete protection, they significantly reduce the disease incidence. Vaccination is especially recommended for at-risk populations and travellers to endemic areas.
Improving sanitation and safe water supply is fundamental to reducing enteric fever incidence. Public health measures, including health education about personal hygiene and food safety, are also essential. Surveillance systems can help monitor disease trends and antibiotic resistance, informing policy and intervention strategies.
Effective management of enteric fever requires a multipronged approach, encompassing early diagnosis, appropriate antimicrobial therapy, vaccination, and public health measures. By integrating these strategies, healthcare professionals can contribute significantly to controlling this persistent global health challenge.
1.
Regular physical activity before cancer diagnosis may lower progression and death risks
2.
Medication Self-Injection Embraced by Breast Cancer Patients
3.
Financial hardship for cancer survivors due to high-cost immunotherapies, especially for blood cancer patients
4.
FDA Advisors Split on Regimens for Breast, Prostate Cancers
5.
ctDNA-Guided Adjuvant Therapy Cuts Bladder Cancer Costs
1.
RDW-CV vs. MCV: Knowing the Difference Can Help You Better Understand Your Health
2.
Clinical Pathways in Hematology in Clinical Decision-Making
3.
Immune Surveillance Screening for Early Cancer Risk Detection
4.
Unlocking the Mysteries of Lymphoblastic Lymphoma: A Journey Into the Unknown
5.
AI-Driven Digital Pathology in Oncology: From Histology Images to Predictive Treatment Biomarkers
1.
International Conference on Innovations in Critical Care for Oncology and Cardiology
2.
International Conference on Oncology, Cardiology and Critical Care Policy
3.
International Conference on Oncology, Cancer Prevention and Public Health
4.
International Conference on Cancer Nursing and Rehabilitation Strategies
5.
International Conference on Best Practices in Oncology, Cardiology and Critical Care
1.
How Advances in Cancer Research Are Improving Treatment Options
2.
Navigating the Complexities of Ph Negative ALL - Part II
3.
Signs and Symptoms of Leukemia
4.
Updates on Standard V/S High Risk Myeloma Treatment- The Next Part
5.
Virtual Case Study on Elephantiasis of Lower Limb- An Initiative by Hidoc Dr.
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation